Barbara Dai

Barbara Dai has worked in the biopharmaceutical industry since 2008. Barbara began their career as a Research Assistant at the National University of Singapore in 2008. In 2011, they became a B&D Associate at EnzymeWorks, Inc. and in 2012, they were promoted to Business Development Manager at PharmaLegacy Laboratories (Shanghai) Co., Ltd. In 2017, they were hired as a Senior Business Development Manager at Beijing Panacea Technology Co., Ltd., where they worked to launch clinical trials in mainland China and collaborate with Taiwan CROs and local Bioanalytical companies. In 2018, they became a Senior Alliances Manager at I-Mab Biopharma and is currently working as an Associate Director at Inmagene Biopharmaceuticals.

Barbara Dai obtained their Master of Science (MS) in Microbiology from Shandong University between 2004 and 2007. Prior to that, they earned their Bachelor's degree in Life Sciences from Jiangsu Normal University between 2000 and 2004.